Show All Results
Healthcare
Life Science
Performance Materials
Find out about outstanding bonds and download our publications for more information.
We value an open and transparent dialogue with our bondholders as well as our shareholders. Currently, the company has several bond issues that trade on the public markets. If you are interested in scheduling a meeting or a call with Merck KGaA, Darmstadt, Germany, please contact Tim Nielsen at +49-6151-72-8680 or Tim.1.Nielsen@emdgroup.com
| Firm | Analyst |
| Barclays Capital | Darren Hook |
| Commerzbank AG | Stefan Kippe |
| Credit Suisse | Sam Morton |
| Citi | Aidan Cheslin |
| Hessische Landesbank | Ulrich Kirschner |
| Landesbank Baden-Würtemberg | Matthias Schell |
| Société Générale | Bob Buhr |
| UniCredit | Dr. Silke Stegemann |
The capital market makes use of the assessments published by independent rating agencies in order to assist debt providers in estimating the risks attaching to a financial instrument. Currently Merck KGaA, Darmstadt, Germany, is assessed by Moody's, Standard & Poors (S&P) and Scope. Rating agencies develop an insight into the strategy and future planning of the companies analyzed thanks to regular discussions with their management. Based on this information and on their own quantitative analyses, the rating agencies assess the creditworthiness of the issuers using rating classifications. The rating is the ticket for admission to the debt capital market.
This website uses 'cookies' to give you the best, most relevant experience. Using this website means you’re Ok with this. You can change which cookies are set at any time - and find out more about them - by following this link: Cookie Policy
The information and documents contained on the following pages of this website are for information purposes only. These materials do neither constitute an offer nor an invitation to subscribe to or to purchase securities, nor any investment advice or service, and are not meant to serve as a basis for any kind of obligation, contractual or otherwise. In particular, the securities described on the following pages are not offered for sale in the United States of America ("US") or to "US persons" (as defined in Regulation S under the US Securities Act of 1933, as amended).
THE FOLLOWING INFORMATION AND DOCUMENTS ARE NOT DIRECTED AT AND ARE NOT INTENDED FOR USE BY (I) PERSONS WHO ARE RESIDENTS OF OR LOCATED IN THE US OR WHO ARE US PERSONS, OR (II) PERSONS IN ANY OTHER JURISDICTION WHERE THE COMMUNICATION OR RECEIPT OF SUCH INFORMATION IS RESTRICTED IN SUCH A WAY THAT PROVIDES THAT SUCH PERSONS SHALL NOT RECEIVE IT. SUCH PERSONS, OR PERSONS ACTING FOR THE BENEFIT OF ANY SUCH PERSONS, ARE NOT PERMITTED TO VISIT THE FOLLOWING PAGES OF THE WEBSITE.
To visit the following parts of this website you must confirm that (i) you are not a resident of the United States of America or a "US person" (as defined in Regulation S under the US Securities Act of 1933, as amended), (ii) you are not a person to whom the communication of the information contained on the website is restricted, (iii) you will not distribute any of the information and documents contained thereon to any such person, and (iv) you are not acting for the benefit of any such person. By clicking on the "Accept" button below, you will be deemed to have made this confirmation.